apoe-genotyping_EURORealTime APOE
Products

Positive opinion on Alzheimer’s drug in Europe – APOE genotyping gets important

On 14th November 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency announced their positive opinion on the marketing authorisation of lecanemab (monoclonal anti-beta-amyloid antibody; trade name: Leqembi from Eisai and Biogen) in the European Union for the treatment of early Alzheimer’s disease in Europe. In 2023, the drug […]

Products

Well prepared for the cold season with the GeneProof portfolio

It is easy to tell that this year‘s cold season, which started at the end of summer with a relatively high number of infections, is now fully on: runny noses, cough, etc. are bringing more and more patients: Runny noses, cough, etc. are bringing more and more patients into the doctor’s practices, as did the

Products

No one-size-fits-all – antibody detection in rheumatology

With passion for rheumatology! Autoantibody testing is becoming increasingly important in rheumatological diagnostics. It delivers crucial information for differential diagnostics and sometimes even allows prediction of the disease progression or helps in the choice of therapy. Before diagnostic use, all serological tests undergo thorough investigation. They are only approved when they meet the respective criteria.

Products

Well prepared for the cold season: the EUROArray PneuVir provides clarity on viral respiratory infections

The start of autumn is currently very noticeable in the northern hemisphere: leaves are changing colour, temperatures are dropping and the days are getting shorter. And in line with this, the German Robert-Koch Institute reports a significantly increased activity for acute respiratory infection in Germany, which is higher than usual for this season. The most

Scroll to Top